Optum joins CVS, Cigna in dropping Humira
(By Rylee Wilson for Becker’s Hospital Review) Optum Rx will join the other major pharmacy benefit managers and exclude Humira
Read More
Part D/Prescription Drugs
Medicare Advantage Quality Bonus Payments Will Total at Least $11.8 Billion in 2024
(By Jeannie Fuglesten Biniek, Meredith Freed, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Sep 11, 2024)
Read MoreNew Alzheimer’s drug faces challenges
(By Alexandra Murphy for Becker’s Hospital Review) Leqembi, an Alzheimer’s drug from Biogen and Eisai, faces hurdles with respect to
Read MoreWith TV Drug Ads, What You See Is Not Necessarily What You Get
(By Elisabeth Rosenthal for KFF Health News) Triumphant music plays as cancer patients go camping, do some gardening, and watch
Read MoreMedicare Advantage members expect more — how top-rated payers respond
(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage beneficiaries are getting savvier and expecting more from their plans, executives
Read More6 drugs now in shortage
(By Paige Twenter for Becker’s Hospital Review) The sole suppliers for a few medications, including a Parkinson’s disease therapy, are
Read MoreMedicare Advantage open enrollment is coming
Did you know Medicare has several different enrollment periods with separate rules for each? There is an Initial enrollment period,
Read MoreThe 3 conditions driving healthcare costs up for employers: Report
(By Mariah Taylor for Becker’s Hospital Review) Pharmacy, cancer and musculoskeletal conditions remain the top drivers of increased healthcare costs
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More5 drugs now in shortage
(By Paige Twenter for Becker’s Hospital Review) About two-thirds of providers recently told Premier their teams are spending more than
Read More